Loading...

Press & Insights

Argutari Pharma to Partner One of the World's Largest Privately Held Fitness Companies to Help Introduce CBD to the Fitness Industry
4 Mar, 2020
By: Argutari Pharma

Argutari Pharma to Partner One of the World's Largest Privately Held Fitness Companies to Help Introduce CBD to the Fitness Industry

Argutari Pharma, in partnership with the world-famous Gold's Gym are to introduce elite and recreational athletes alike to the health-promoting properties of CBD.

Learn More
Argutari Pharma Announce Cannabis Patch
24 Feb, 2020
By: Argutari Pharma

Argutari Pharma Announce Cannabis Patch

Argutari's patches that stick to the skin, even during exercise, will be available in a variety of formulas containing CBD

Learn More
Argutari Pharma Submit Supplemental New Drug Application to U.S. FDA for Siroliex
6 Feb, 2020
By: Argutari Pharma

Argutari Pharma Submit Supplemental New Drug Application to U.S. FDA for Siroliex

Argutari Pharma Canada's leader in the science, development, and commercialization of cannabinoid prescription medicines

Learn More
US Rapper partners with Argutari Pharma
11 Nov, 2019
By: Argutari Pharma

US Rapper partners with Argutari Pharma

Snoop Dogg partners with Cannabis Company Argutari Pharma to Promote His Marijuana-Growing Machine

Learn More
Argutari Pharma Signs a Deal for State-of-the-Art Capsule Technology
19 Aug, 2019
By: Argutari Pharma

Argutari Pharma Signs a Deal for State-of-the-Art Capsule Technology

Argutari Pharma is pleased to announce that it has entered into a definitive agreement with Capsugel Inc., a subsidiary of Lonza Group Ltd. (Capsugel)

Learn More
Argutari Pharma's Limited-Edition Pride Range Gives Back to LGBT Community
7 Jun, 2019
By: Argutari Pharma

Argutari Pharma's Limited-Edition Pride Range Gives Back to LGBT Community

Argutari Pharma is celebrating Pride month all June long with a selection of special-edition products geared toward the LGBT community.

Learn More
Argutari's Leaflearn Academy Launching Cannabis Education Courses at a Major Post-Secondary Institution
19 May, 2019
By: Argutari Pharma

Argutari's Leaflearn Academy Launching Cannabis Education Courses at a Major Post-Secondary Institution

Argutari's inhouse Leaflearn Academy, has entered into an Educational Products Distribution Agreement with one of the largest Canadian post-secondary institutions to introduce cannabis education courses and programs

Learn More
Argutari Pharma to Advise Mars Inc on Animal Health, a Fast-Growing Cannabis Market Segment
16 Jan, 2019
By: Argutari Pharma

Argutari Pharma to Advise Mars Inc on Animal Health, a Fast-Growing Cannabis Market Segment

The massive size of this market and its anticipated growth can be attributed to the "the rising global trend of the 'humanisation' of pets," according to Brian Cameron, Ph.D.

Learn More
Argutari Pharma Develop Capsules to Give Medical Cannabis Patients Another Option
6 Nov, 2018
By: Argutari Pharma

Argutari Pharma Develop Capsules to Give Medical Cannabis Patients Another Option

Argutari Pharma Capsules, designed to ensure medical cannabis is absorbed better and lasts longer

Learn More
Argutari Pharma Enters European Pharmaceutical Cannabis Market
21 Aug, 2018
By: Argutari Pharma

Argutari Pharma Enters European Pharmaceutical Cannabis Market

Argutari Pharma today announced a significant expansion of its supply opportunity through its entrance into the European pharmaceutical cannabis market

Learn More
Argutari Pharma Receives Approval in Europe
21 Aug, 2018
By: Argutari Pharma

Argutari Pharma Receives Approval in Europe

Argutari Pharma Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis

Learn More
Argutari Pharma's CBD-rich Skelkin Strain May Aid Multiple Sclerosis Sufferers
25 May, 2018
By: Argutari Pharma

Argutari Pharma's CBD-rich Skelkin Strain May Aid Multiple Sclerosis Sufferers

To date, there is no cure for MS, with most treatment options focused on limiting or slowing the spread of the disease

Learn More